Gene Query: RPP25L

Dataset Description Geneva Score
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 13.62
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 12.95
RNA-seq of IL-4 stimulated human keratinocytes 11.96
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 11.65
Transcriptome-wide identification of CELF2 functional targets in T cells 11.04
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.46
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.95
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.05
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.91
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.73
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.43
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.05
Glioblastoma stem cells infected by ZIKA virus 5.98
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.75
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 5.39
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 5.06
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.03
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 4.86
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.74
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.65
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.65
CROP-Seq in Primary Human T Cells 4.61
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.41
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.37
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.26
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.2
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.17
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.13
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.98
Effect of CHKA knockdown on C4-2 cell transcriptome 3.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.84
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.84
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.81
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.73
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.64
m6A-dependent regulation of messenger RNA stability 3.56
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.52
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.43
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.43
Survival of pancreatic cancer cells lacking KRAS function 3.4
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.39
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.39
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.38
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.37
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.36
Impact of dieldrin on transcription in Jurkat T cells 3.25
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.25
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 3.25
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.24
Global analysis of enhancer targets: Mosaic-seq 3.21
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.19
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.09
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.03
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.01
Identification of global regulators of T-helper cell lineage specification 3.01
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.01
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.99
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.98
Rorc disruption in human FG pancreatic cancer cells 2.88
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 2.88
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.8
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.78
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.77
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.74
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.74
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.71
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.7
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.7
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.67
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 2.55
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.52
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.51
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.49
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.47
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.45
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.45
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.39
Nutritional control of protein translation 2.37
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.35
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.35
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.32
Energy Metabolism during Anchorage-Independence 2.32
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.28
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.28
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.27
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.25
Pharmacologic inhibition of STAT5 in AML 2.25
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.24
Identification of renal resident macrophages across species 2.24
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.22
NR2F2 study 2.22
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.22
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.21
scRNASeq analysis of cycling cardiomyocytes 2.2
Identification of HOXB13 target genes responsive to BET inhibitors 2.15
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.14
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.1
H1609088 Human RNA-Sequencing 2.09
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.08
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.08
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.07
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.07
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.07
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.06
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.02
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 2.01
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.01
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.0
Global analysis of alternative splicing regulated by RBM10 2.0
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 2.0
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.99
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 1.98
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.97
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 1.96
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.92
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.91
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.88
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.88
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.88
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.86
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.85
Discovering human diabetes-risk gene function with genetics and physiological assays 1.84
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.83
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.83
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.83
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.81
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 1.8
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.79
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.77
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.77
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 1.76
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.76
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 1.75
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.75
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.74
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.73
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.72
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.71
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.71
Targeting MTHFD2 in Acute Myeloid Leukemia 1.71
Single-Cell Genotyping of Transcriptomes 1.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.69
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.69
DRB/GRO-Seq -/+ UV 1.69
Lipid degradation promotes prostate cancer cell survival 1.68
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.67
Transcriptome analysis of SKI knock-out in HL60 cells 1.67
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 1.66
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.65
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 1.63
Integrating single-cell transcriptomic data across different conditions, technologies, and species 1.61
The transcriptome effect of overexpressing EZH2 in MCF7 1.6
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 1.59
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.59
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.59
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.59
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 1.59
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.57
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.57
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.57
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.57
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.57
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 1.57
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.56
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.56
Paxillin regulates genomic networks in prostate cancer [LNCaP] 1.56
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.55
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 1.53
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 1.52
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 1.52
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.51
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.51
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.5
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.5
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.5
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.5
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.49
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.49
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.49
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.49
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.49
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 1.47
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.47
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.44
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.44
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.44
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 1.42
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.4
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 1.39
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.38
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.37
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.37
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.34
LncRNA expression profiling of ischemic stroke patients 1.33
JAK dependent survival of ALK- ALCL 1.32
hnRNP C is a key regulator of protein synthesis in mitosis 1.31
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.3
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 1.3
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 1.3
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 1.29
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 1.29
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.27
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 1.26
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 1.26
MeRIP-seq for heat shock in B-cell lymphoma cells 1.25
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 1.25
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.24
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.23
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.23
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.23
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.23
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 1.22
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 1.22
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 1.22
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 1.22
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.21
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.2
RNA-seq of YB5 cells treated with Proscillaridin A 1.2
HEK293 TFAM Knockout Expression Study 1.2
Transcriptional profile in human S. haematobium infection 1.19
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 1.19
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.18
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.18
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.18
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 1.18
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 1.18
Effect of PBK knockdown on C4-2 cell transcriptome 1.17
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.17
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.17
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 1.16
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.15
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.15
DART-seq: an antibody-free method for global m6A detection 1.15
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.15
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 1.15
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.14
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.12
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.12
Seletive inhibition of CDK9 in DLBCL cell lines 1.12
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.11
SNHG5 siRNA knock down in HCT116 cells 1.11
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 1.11
Controlling for gene expression changes in transcription factor protein networks. 1.1
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.09
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.07
RNA-Seq and expression data from human adipose tissue 1.07
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.07
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.07
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.06
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.06
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.04
Transcriptome-wide modulation of splicing by the exon junction complex 1.03
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.03
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.02
Electronic cigarettes 1.02
Chromatin landscape of human visceral and subcutaneous adipocytes 1.01
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.01
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.01
Gene expression in GBM with Cav3.2 inhibition 1.0
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.99
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.99
RNA-Seq from human ILC transitional populations 0.99
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.98
Gene expression profiling of leukemia cells following asparagine depletion 0.98
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.98
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.98
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.97
Human Treg IL-12 stimulation 0.97
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.97
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.96
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.96
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.95
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.95
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 0.94
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 0.93
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.92
Functional significance of the HIV-1 Tat signature amino acid residues 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.91
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.91
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.9
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.9
N6-methyladenine DNA Modification in Glioblastoma 0.9
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 0.9
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.89
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.89
HNRNPM-regulated splicing dependencies in prostate cancer 0.89
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 0.89
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.88
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.87
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.87
Exploring ILF2 regulatory genes by next-generation sequencing 0.86
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.86
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.86
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 0.86
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.85
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.83
Single-cell analysis of adult human ovary using 10X genomics 0.83
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.83
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.82
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.82
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.82
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.81
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.81
Transcriptional profiling of microglia; current state of the art and future perspectives 0.81
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.8
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.8
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.8
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.8
Human Treg NaCl stimulation 0.79
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 0.79
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.78
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.78
RNA-seq analysis of control and Myc-induced U2OS cells 0.78
ETV7 and interferon response 0.78
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.78
Single-cell analysis of human kidney organoids 0.77
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.76
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.76
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.75
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.75
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.75
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.75
Paxillin regulates genomic networks in prostate cancer [C4-2] 0.74
RNA-seq analyisis of PUM2 knockout cells 0.74
RNA-seq of tumor cells following angiopellosis extravasation 0.74
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.74
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.73
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.73
Loss of CREBBP results in gene expression repression in lymphoma cells 0.73
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.73
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.71
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 0.7
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.68
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.67
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.67
RNAseq of cell lines with knocked in ESR1 mutations 0.67
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.65
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.65
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.64
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.63
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.63
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.62
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.62
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.61
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.6
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.6
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.6
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 0.6
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.6
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.59
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.59
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.58
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.57
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.57
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.57
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.56
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.55
Gene expression signatures of innate lymphoid cells from human blood 0.55
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.55
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.55
Mapping interactions for the TNIP2 hub protein 0.54
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.54
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.54
Identification of long noncoding RNAs in T-ALL cell lines 0.52
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.52
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.51
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.5
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.49
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.48
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.48
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.46
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.45
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.44
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.44
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.44
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.44
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.43
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.42
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 0.41
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 0.41
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.41
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.41
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.4
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.4
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.39
Effect of nuclear IL-33 on gene expression 0.39
Comparative Analysis of Cas9 Activators Across Multiple Species 0.39
miRNAs affected by antagomiR-17 treatment 0.38
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.37
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 0.37
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.37
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.36
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.36
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.35
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.34
Effect of ILF3 on translation during homeostasis and the antiviral response 0.34
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.33
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.33
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.33
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.32
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.3
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.3
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.3
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.29
Ribosomal protein RPL26 is the principal target of UFMylation 0.29
Single cell transcriptome of peritoneal cells 0.28
Human Treg IFNg/IL-10 subpopulations 0.28
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.27
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.27
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.27
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.27
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.27
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.26
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.26
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.26
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.26
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.26
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.25
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.25
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.24
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.23
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.23
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.23
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.23
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.23
Expression analysis of the TAF1 syndrome 0.23
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.23
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.23
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.23
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.22
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.22
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.22
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.22
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.21
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.21
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.2
Androgen Receptor-regulated genes in prostate cancer cells 0.2
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.2
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.2
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.2
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.19
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.18
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.18
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.17
quanTIseq: quantifying immune contexture of human tumors 0.17
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.17
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.17
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.16
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.16
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.15
A single cell reference map for human blood and tissue T cell activation 0.15
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.15
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.14
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.14
Gene expression changes due to PARP knockdown in human cells 0.13
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.12
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.12
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.12
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.12
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.12
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.12
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.12
CDK4/6 inhibitor resistance in prostate cancer 0.11
Regulation of poly(A) tail and translation during the somatic cell cycle 0.11
Transcriptome of EBV-infected gastric cancer cell lines 0.11
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 0.11
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 0.11
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.1
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.1
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.1
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.1
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.09
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.09
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.09
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.08
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.08
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.08
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.08
The circadian transcriptional landscape in primary human mammary epithelial cells 0.07
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.04
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.04
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.02
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.01
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.01
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.01
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.0
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation